A detailed history of M3 Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, M3 Advisory Group, LLC holds 610 shares of LLY stock, worth $473,591. This represents 0.4% of its overall portfolio holdings.

Number of Shares
610
Previous 702 13.11%
Holding current value
$473,591
Previous $635 Million 14.95%
% of portfolio
0.4%
Previous 0.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$772.14 - $960.02 $71,036 - $88,321
-92 Reduced 13.11%
610 $540 Million
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $105,106 - $131,810
145 Added 26.03%
702 $635 Million
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $100,674 - $134,687
170 Added 43.93%
557 $433 Million
Q4 2023

Mar 19, 2024

BUY
$525.19 - $619.13 $203,248 - $239,603
387 New
387 $226 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $738B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track M3 Advisory Group, LLC Portfolio

Follow M3 Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M3 Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M3 Advisory Group, LLC with notifications on news.